WealthOne’s DexCom DXCM Stock Holding History

WealthOne’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,836	Closed	-$251K	–	116
2021 Q3	$251K	Buy	+1,836	New	+$232K	0.09%	115
2019 Q1	–	Sell	-680	Closed	-$20K	–	191
2018 Q4	$20K	Buy	+680	New	+$21.6K	0.02%	284

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WealthOne's DXCM Position: Q4 2021 in Review

WealthOne sold out of DexCom (DXCM) in Q4 2021, closing a stake of 1,836 shares — an estimated $251K sold.

WealthOne first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $251K in Q3 2021. 931 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

WealthOne reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
WealthOne sold 1,836 DexCom shares in Q4 2021, an estimated $251K.
WealthOne first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
WealthOne's DexCom position peaked at $251K in Q3 2021.
931 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on WealthOne's 13F filing for Q4 2021, filed 11 Feb 2022.